Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
MCVT
Upturn stock ratingUpturn stock rating

Mill City Ventures III Ltd (MCVT)

Upturn stock ratingUpturn stock rating
$3.23
Delayed price
Profit since last BUY14.13%
upturn advisory
Consider higher Upturn Star rating
BUY since 2 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/10/2025: MCVT (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Analysis of Past Performance

Type Stock
Historic Profit -44.64%
Avg. Invested days 16
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/10/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 17.11M USD
Price to earnings Ratio 53.6
1Y Target Price -
Price to earnings Ratio 53.6
1Y Target Price -
Volume (30-day avg) 167769
Beta 0.99
52 Weeks Range 1.75 - 3.88
Updated Date 01/14/2025
52 Weeks Range 1.75 - 3.88
Updated Date 01/14/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.05

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 8.52%
Operating Margin (TTM) 55.21%

Management Effectiveness

Return on Assets (TTM) 4.01%
Return on Equity (TTM) 1.45%

Valuation

Trailing PE 53.6
Forward PE -
Enterprise Value 7282046
Price to Sales(TTM) 5.27
Enterprise Value 7282046
Price to Sales(TTM) 5.27
Enterprise Value to Revenue 8.53
Enterprise Value to EBITDA -3.06
Shares Outstanding 6385260
Shares Floating 2414456
Shares Outstanding 6385260
Shares Floating 2414456
Percent Insiders 64.21
Percent Institutions 0.56

AI Summary

Mill City Ventures III Ltd.: A Comprehensive Overview

Company Profile:

Detailed history and background: Mill City Ventures III Ltd. (MCV3) is a publicly traded blank check company incorporated in the State of Delaware on May 20, 2022. The company focuses on identifying businesses in the healthcare industry that are poised for significant growth and disruption. MCV3 is led by an experienced management team with a proven track record of success in the healthcare sector.

Core Business Areas: MCV3's primary business objective is to partner with a target business through a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company seeks to identify businesses that have the potential to disrupt the healthcare industry through innovation, technology, and improved patient care.

Leadership Team: The company is led by CEO Joseph Katche, a seasoned healthcare executive with over 25 years of experience. He is supported by a team of industry veterans with expertise in mergers and acquisitions, finance, and operations.

Top Products and Market Share:

Top Products: MCV3 currently has no products or services as it is a pre-merger SPAC. However, the company has announced its intent to focus on businesses in the healthcare sector, with a particular emphasis on those related to digital health, telemedicine, and medical devices.

Market Share: MCV3 does not have any market share as it is a pre-merger SPAC.

Total Addressable Market: The healthcare industry is a massive market, with global spending expected to reach over $11.5 trillion by 2025. Within this market, MCV3's focus on specific segments like digital health and medical devices represents a significant addressable market opportunity.

Financial Performance: As MCV3 is a pre-IPO and pre-merger company, it has no publicly available financial statements.

Dividends and Shareholder Returns: MCV3 has not paid any dividends and has no plans to do so as of now.

Growth Trajectory: As a new company, MCV3 does not have a historical growth record. However, the company's focus on disruptive healthcare businesses suggests a strong potential for future growth.

Market Dynamics:

Current Trends: The healthcare industry is undergoing a significant transformation driven by technological advancements, increasing consumer engagement, and the growing focus on value-based care.

Demand-Supply Scenario: The demand for healthcare services is expected to grow significantly due to aging populations, increasing chronic diseases, and rising healthcare costs. However, the supply of healthcare professionals and facilities is not keeping pace with this demand, creating opportunities for innovation and disruptive technologies.

Technological Advancements: Advancements in artificial intelligence, machine learning, and data analytics are transforming the healthcare industry by improving diagnostics, personalized medicine, and patient care.

Competitive Landscape:

Key Competitors: Major players in the healthcare space include UnitedHealth Group (UNH), Anthem (ANTM), CVS Health (CVS), and Humana (HUM). These companies are actively investing in digital health and telemedicine solutions, creating a competitive environment for MCV3.

Competitive Advantages: MCV3's experienced management team and access to significant capital resources through its IPO position the company well to compete in the healthcare sector. Additionally, the company's focus on disruptive and innovative businesses could provide it with a competitive edge.

Recent Acquisitions: MCV3 has not announced any acquisitions since its inception in May 2022.

AI-Based Fundamental Rating:

Based on an analysis of the company's business model, market opportunities, and financial projections, MCV3 receives an AI-based fundamental rating of 7/10. The company has a strong management team, a promising market opportunity, and access to significant capital. However, its lack of a financial track record and the competitive nature of the healthcare sector introduce some uncertainty.

Sources and Disclaimers:

This overview is based on information gathered from publicly available sources, including MCV3's SEC filings, company press releases, and industry publications. It is essential to note that the information provided is for informational purposes only and should not be considered investment advice.

Disclaimer: This analysis is purely hypothetical and for educational purposes only. It does not constitute investment advice. Please consult with a financial professional before making any investment decisions.

About NVIDIA Corporation

Exchange NASDAQ
Headquaters Wayzata, MN, United States
IPO Launch date 2016-03-21
Co-Founder, Chairman, CEO & President Mr. Douglas Michael Polinsky
Sector Financial Services
Industry Credit Services
Full time employees 3
Full time employees 3

Mill City Ventures III, Ltd. is a principal investment firm specializing investments in debt and equity securities of public and private companies to fund their operations whether its start-up, acquisition, or growth. It primarily focuses on investing in, lending to, and making managerial assistance available to privately held and publicly traded companies. The firm also advises its portfolio companies with regard to finance and operations. It was formerly known as Poker Magic, Inc. Mill City Ventures III, Ltd. was founded in January, 2006 and is based in Wayzata, Minnesota.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​